Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome

Abstract

Our results establish Sox9 as a dosage-sensitive modifier of Jag1^+/- liver phenotypes with a permissive role in biliary development. Our data further suggest that liver-specific increase in SOX9 levels is a potential therapeutic approach for BD paucity in ALGS.